CVS Caremark Settles FTC Insulin Lawsuit, CVS Got Paid More When Insulin Cost More. The FTC Is Forcing That to Stop.
CVS Health’s pharmacy benefit manager, Caremark, reached a proposed settlement with the Federal Trade Commission on March 24, 2026, becoming the second of the three largest drug middlemen in the U.S. to resolve federal allegations that their business practices drove insulin prices higher — and then profited from the result. The proposed consent agreement was…
